About this Research Topic
The entity of heart failure with preserved ejection fraction (HFpEF) has gained interest in the past few years given that it accounts for approximately half the burden of heart failure prevalence. AF prevalence in patients with HFpEF is reported to be up to 60%. However, there is still a dearth of data in this regard, with most studies focusing on heart failure with reduced ejection fraction.
Symptomatology of AF and HFpEF often overlap contributing to underdiagnosis of co-existence of both entities in the same patient. AF combined with HFpEF poses increased morbidity and mortality. Furthermore, the cause-and-effect theory warrants attention. HFpEF results in atrial remodeling (thus increased AF burden) and AF by itself can alter the hemodynamics and cellular mechanisms affecting ventricular function. Hence, it is worth evaluating the uniqueness of its pathophysiology, epidemiology, and various management options.
We welcome papers that focus on but are not limited to:
1. Changes in cardiac biomarkers in patients with HFpEF and atrial fibrillation
2. Effect of increased AF burden on hospitalizations and healthcare costs in patients with HFpEF
3. Efficacy of rhythm control on HFpEF patients
4. Catheter ablation for AF in HFpEF (safety, efficacy, and improvement in quality of life)
5. Electrical remodeling and anatomical changes in atria in patients with AF and HFpEF
6. Imaging characteristics of cardiac chambers in patients with concomitant AF with HFpEF.
7. Hemodynamics and cardiopulmonary exercise test findings in AF with HFpEF
8. Studying cause and effect/temporal trends in AF and HFpEF
9. AF related heart failure prevention strategies
10. Role of AF monitoring in patients with HFpEF
Symptomatology of AF and HFpEF often overlap contributing to underdiagnosis of co-existence of both entities in the same patient. AF combined with HFpEF poses increased morbidity and mortality. Furthermore, the cause-and-effect theory warrants attention. HFpEF results in atrial remodeling (thus increased AF burden) and AF by itself can alter the hemodynamics and cellular mechanisms affecting ventricular function. Hence, it is worth evaluating the uniqueness of its pathophysiology, epidemiology, and various management options.
We welcome papers that focus on but are not limited to:
1. Changes in cardiac biomarkers in patients with HFpEF and atrial fibrillation
2. Effect of increased AF burden on hospitalizations and healthcare costs in patients with HFpEF
3. Efficacy of rhythm control on HFpEF patients
4. Catheter ablation for AF in HFpEF (safety, efficacy, and improvement in quality of life)
5. Electrical remodeling and anatomical changes in atria in patients with AF and HFpEF
6. Imaging characteristics of cardiac chambers in patients with concomitant AF with HFpEF.
7. Hemodynamics and cardiopulmonary exercise test findings in AF with HFpEF
8. Studying cause and effect/temporal trends in AF and HFpEF
9. AF related heart failure prevention strategies
10. Role of AF monitoring in patients with HFpEF
Keywords: Atrial Fibrillation, HFpEF, Diastolic heart failure, Catheter ablation
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
